CN103919175A - Prawn sausage - Google Patents
Prawn sausage Download PDFInfo
- Publication number
- CN103919175A CN103919175A CN201410175285.2A CN201410175285A CN103919175A CN 103919175 A CN103919175 A CN 103919175A CN 201410175285 A CN201410175285 A CN 201410175285A CN 103919175 A CN103919175 A CN 103919175A
- Authority
- CN
- China
- Prior art keywords
- kilogram
- prawn
- sausage
- liquid extract
- lycopodium calvatum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000238557 Decapoda Species 0.000 title claims abstract description 39
- 235000013580 sausages Nutrition 0.000 title abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 33
- 201000001421 hyperglycemia Diseases 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 235000019991 rice wine Nutrition 0.000 claims abstract description 7
- 239000008159 sesame oil Substances 0.000 claims abstract description 7
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 7
- 241000195947 Lycopodium Species 0.000 claims description 24
- 210000000936 intestine Anatomy 0.000 claims description 18
- 230000036541 health Effects 0.000 claims description 15
- 244000197580 Poria cocos Species 0.000 claims description 11
- 241000110637 Cuscuta chinensis Species 0.000 claims description 10
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 10
- 244000215777 Plumeria rubra Species 0.000 claims description 10
- 235000013087 Plumeria rubra Nutrition 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 229960002675 xylitol Drugs 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- 239000000811 xylitol Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 abstract description 25
- 239000008280 blood Substances 0.000 abstract description 25
- 210000004072 lung Anatomy 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 10
- 235000013372 meat Nutrition 0.000 abstract description 8
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 210000002216 heart Anatomy 0.000 abstract description 4
- 210000003205 muscle Anatomy 0.000 abstract description 4
- 230000003014 reinforcing effect Effects 0.000 abstract description 4
- 230000035922 thirst Effects 0.000 abstract description 4
- 210000001835 viscera Anatomy 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 241000195954 Lycopodium clavatum Species 0.000 abstract 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- 241000438687 Juncus roemerianus Species 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 208000002173 dizziness Diseases 0.000 abstract 1
- 238000010791 quenching Methods 0.000 abstract 1
- 230000000171 quenching effect Effects 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 235000013599 spices Nutrition 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 25
- 239000003814 drug Substances 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 108010023302 HDL Cholesterol Proteins 0.000 description 6
- 108010028554 LDL Cholesterol Proteins 0.000 description 6
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229960004580 glibenclamide Drugs 0.000 description 3
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 201000009361 ascariasis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000003445 biliary tract Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/40—Shell-fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a prawn sausage, relates to a healthcare prawn sausage for preventing and treating hyperglycemia, and provides a healthcare prawn sausage for preventing and treating hyperglycemia. The healthcare prawn sausage is characterized by comprising the following raw materials by weight: 8-10kg of prawn meat, 0.5-1.5kg of common clubmoss herb liquid extract powder, 0.2-0.4kg of salt, 0.4kg of newtol, 0.7kg of Shaoxing rice wine, 0.4kg of sesame oil and 0.05kg of five spice powder. The balance of five internal organs, namely heart, liver, spleen, lung and kidneys of a human body is adjusted by frangipane, semen cuscutae, tuckahoe, ophiopogon root and juncus roemerianus, and the prawn sausage is used for dispersing blood stasis, removing turbidity and quenching thirst, and also used for relaxing the muscles and stimulating the blood circulation, and tonifying qi and dredging collaterals by using lycopodium clavatum, so as to reduce blood sugar level. The prawn meat is used for tonifying kidneys and reinforcing yang, and nourishing yin and relieving dizziness. The healthcare prawn sausage disclosed by the invention can properly replenish nutrients and also can prevent and control hyperglycemia after being often eaten.
Description
Technical field
The present invention relates to a kind of health care to shrimp intestines, especially a kind of health care that prevents and treats hyperglycaemia is to shrimp intestines.
Background technology
When exceeding the level of regulation, blood glucose value will form hyperglycemia.Diabetes are to continue a kind of chronic general metabolic disease that hyperglycaemia is its basic biochemical character, mainly definitely to lack or because health increases the insulin relative deficiency causing to the demand of insulin due to insulin secretion in body, or due to insulin resistance, thereby cause take a kind of syndrome of carbohydrate metabolism disturbance as main sugar, protein, fat metabolic disturbance; Hyperglycaemia or diabetic guarantee the absorption of protein, and protein is supplied with first-selected good protein, as milk, egg, lean meat etc.
Diabetes, in the traditional Chinese medical science, are mainly that the five internal organs are weak due to the plain body deficiency of Yin, multiple because of eating and drinking without temperance, overfeeding delicious food, and disorder of emotion, labor is wanted excessively, and causes deficiency of kidney-YIN, and lung stomach is scorching; Interpretation of the cause, onset and process of an illness emphasis is that the deficiency of Yin is scorching, and take the deficiency of Yin as this, and scorching is mark; With the passing of time disease prolongs, yin deficiency affecting yang, deficiency in both YIN and YANG; The deficiency of Yin is scorching, and the bright liquid in consumption Tianjin makes blood viscous, the not smooth stasis of blood that forms of blood; Yin deficiency affecting yang, the deficiency of yang is cold solidifying, also can cause sun in hemostasis.
Shrimp is nutritious, and its meat is soft, easy to digest, to people in poor health and that need after being ill to take good care of, is fabulous food.In shrimp, contain abundant magnesium, magnesium has important regulating action to cardiomotility, can well protect cardiovascular system, and it can reduce Blood Cholesterol content, prevents artery sclerosis, simultaneously can also coronary artery dilator, be conducive to preventing hypertension and myocardial infarction.It is sweet that the herbal > > of < < China records prawn taste; Salty; Warm in nature; Function cures mainly: kidney tonifying Xing Yang, nourishing yin to calm the wind.Main impotence due to deficiency of the kidney; Wind formation from yin deficiency; Tetany; Apoplexy and hemiplegia; Breast sore; With the passing of time ulcer do not hold back.
Prior art does not have health care that application prevents and treats hyperglycaemia to the preparation of shrimp, lycopodium calvatum to shrimp intestines, and the single and health care of taste has its limitation.Invention---the processing technology of shrimp intestines that the patent No. that Ru Chinese patent information centre announces is 201310346364.0, this disclosure of the invention a kind of processing technology of shrimp intestines, it is characterized in that: select materials → pretreatment of raw material → dry → add batching → filling → quantitatively, compress → freeze → visit → keeping of packing → gold.Technique of the present invention is improved in the method for making of traditional shrimp intestines, compares with traditional shrimp intestines technique, and technique of the present invention is after using flavoring salt, pepper powder, sticky powder, true mushroom accurate adjustment taste, through vacuum compression, shrimp intestines are good looking appearance not only, and meat compacts, taste is fragrant, and mouthfeel is good, nutritious; This invention health care has its advantage, but also has weak point.
Summary of the invention
In order to solve prior art problem, the object of the invention is to provide a kind of health care that prevents and treats hyperglycaemia to shrimp intestines.
Technical scheme: a kind of health care that prevents and treats hyperglycaemia, to shrimp intestines, comprises the raw material of following weight: to shrimp 8-10 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, salt 0.2-0.4 kilogram, 0.4 kilogram of xylitol, 0.7 kilogram of Shaoxing rice wine, 0.4 kilogram of sesame oil, 0.05 kilogram of five-spice powder; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
Preparation method: 1, first rub into meat stuffing shrimp is put into meat grinder, then mix into pasty state thoroughly together with putting in container with other batching, pickle 2-4 hour, enter sausage filler; 2. sausage filler is inserted in in casing one end and records, record full, mono-of every 20CM, button is beaten at two; Sausage is air-dry 3., then put into steam copper, boiling 20-30 minute is well-done, takes out cooling.
As optimization, a kind of health care that prevents and treats hyperglycaemia of the present invention, to shrimp intestines, comprises the raw material of following weight: to shrimp 8-10 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, salt 0.2-0.4 kilogram, 0.4 kilogram of xylitol, 0.7 kilogram of Shaoxing rice wine, 0.4 kilogram of sesame oil, 0.05 kilogram of five-spice powder; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Lycopodium calvatum, toil temperature, expelling wind and clearing away cold, dehumidifying are subsided a swelling, are stimulated the circulation of the blood and cause the muscles and joints to relax.< < Hunan medicine will > > records lycopodium calvatum: sweet, flat.Nontoxic, enter the heart, kidney two warps, relax the muscles and stimulate the blood circulation, invigorating qi and dredging collateral.
Frangipanis, cool in nature, taste is sweet, light; Return large intestine, stomach warp, there is the effect of moistening lung removing toxic substances, clearing heat and expelling damp, laxation.
Radix Glycyrrhizae taste is sweet, flat.The thoughts of returning home, lung, spleen, stomach warp.Function cures mainly: invigorates the spleen and benefits qi, and clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription.For weakness of the spleen and the stomach, lassitude hypodynamia, palpitation, coughing with a lot of sputum, gastral cavity abdomen, the anxious pain of four limbs contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Seed of Chinese dodder acrid-sweet flavor, property is flat, enters liver, kidney two warps.There is tonifying kidney and benefiting sperm, nourish the liver to improve visual acuity, antiabortive effect.
Poria cocos taste is sweet, light, property is flat, be used as medicine there is clearing damp and promoting diuresis, the function of beneficial spleen and stomach, antitoxic heart-soothing and sedative.Modern medicine study: Poria cocos energy enhanced machine body immunity function, pachymaran has significantly antitumor and protect the liver dirty effect.
The tuber of dwarf lilyturf, the micro-sugariness of property is bitter, cold, has nourishing Yin and moistening lung, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, reinforcing yin essence benefit essence, five viscera settling effect.
Rush, is slightly cold; Sweet, light; The thoughts of returning home; Lung; Small intestine; Urinary bladder channel.Effect: promoting diuresis for stranguria; Clearing heart fire.Dark plum is sour, puckery, flat, returns liver, spleen, lung, large intestine channel.[function cures mainly] astringes the lung, and puckery intestines, promote the production of body fluid, claming ascaris.For chronic cough of deficiency lung, protracted dysentery laxation, abnormal heat is quenched one's thirst, ascariasis of biliary tract vomiting stomachache, ascariasis of biliary tract (< < Chinese pharmacopoeia > >).
Advantage of the present invention: 1, lycopodium calvatum Xin Wenyi impairment of yin blood of the present invention, therefore adapted frangipanis, Radix Glycyrrhizae are in harmonious proportion, make its institute partially, its taste is glycol, fresh and sweet, has channels sootheing and network vessel quickening, function of promoting blood circulation to disperse blood clots.
2, taste glycol of the present invention is pure and fresh, has increased the novel taste of sausage.Seed of Chinese dodder tonifying kidney and benefiting sperm, Poria cocos clearing damp and promoting diuresis, beneficial spleen and stomach, the tuber of dwarf lilyturf is nourishing Yin and moistening lung, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, and rush clearing heart fire, dark plum are quenched one's thirst and are brought down a fever, and more contribute to promoting blood circulation and removing blood stasis hypoglycemic.
3, the present invention is by the balance of frangipanis, the seed of Chinese dodder, Poria cocos, the tuber of dwarf lilyturf, rush conditioning human body-centered liver spleen lung kidney the five internal organs, and stagnation resolvation is pure and impure quenches one's thirst, and relax the muscles and stimulate the blood circulation again, thereby invigorating qi and dredging collateral reaches hypoglycemic object with lycopodium calvatum; To shrimp kidney tonifying Xing Yang, nourishing yin to calm the wind, often edible the present invention's health care, to shrimp intestines, can suitably supplement the nutrients, and can prevent and control hyperglycaemia again.
4, Chinese medicine powder of the present invention has significant hypoglycemic activity to adrenaline hyperglycaemia mouse and alloxan hyperglycemia mouse.Each 20 of male and female mices are selected in experiment; Adopt respectively adrenaline and alloxan to set up hyperglycaemia mouse model, then give Chinese medicine powder of the present invention, glibenclamide, insoral is treated and survey blood sugar level.In the hyperglycemia mouse of bringing out at adrenaline, Chinese medicine powder of the present invention can make fasting serum glucose [(16. 58 ± 3. 92) mmol/L] be reduced to (7. 56 ± 2. 63) mmol/L, effect and glibenclamide comparison, no significant difference (P>0.05); In the hyperglycemia mouse of model induced by alloxan, the present invention is reduced to fasting serum glucose [(15. 56 ± 1. 83) mmol/L] (7. 55 ± 1.65) mmol/L, blood sugar reducing function is significantly better than insoral (P<0 05), and causes hypoglycemic side effect without glibenclamide.Conclusion: the present invention can significantly reduce the blood sugar level (P <0. 001) of 2 kinds of modeling animals, and makes blood sugar be down to normal level.
5, Chinese medicine powder of the present invention shows through more than the 60 routine sugared dung patients' that make a definite diagnosis clinical observation on the therapeutic effect, and the present invention has remarkable reduction glycosuria patient's blood sugar level, makes blood sugar recovery normal.
Clinical observation result of the present invention:
1.1 physical data: select the People's Hospital, city outpatient service diabetes B patient 60 examples, be divided at random two groups.Treatment group 30 examples, male 16 examples, female's 14 examples, 30～70 years old age, average (50 ± 1.5) year, the course of disease 6 months～15 years, average (8.0 ± 1.2) year; Control group 30 examples, male 18 examples, female's 12 examples, 29～70 years old age.Two groups of physical data comparing difference not statistically significants (P>0.05), have comparativity.
1.2 case selections: with reference to the World Health Organization's (WHO) diabetes diagnosis in 1999 and somatotype standard [1]: diabetic symptom+random time plasma glucose levels >=11.1mmol/L(200mg/dl).The patient's random packet that meets above-mentioned standard is carried out to observational study, and the patient that part takes traditional Chinese medicine stops former Chinese medicine and includes observation in after 2 weeks, and the patient's to be directly brought into not taking traditional Chinese medicine is observed.Two groups of patients all give diabetes Primary Care, comprise diet control, kinesiatrics and orally-taken blood sugar reducing Western medicine, and hypoglycemic Western medicine adopts melbine, according to blood sugar situation, carries out drug usage and dose adjustment.
1.3 methods of treatments: treatment group is taken Chinese medicine powder of the present invention taking on the basis of melbine.Basic side is comprised of the composition of raw materials of following weight portion: lycopodium calvatum 10, frangipanis 10, Radix Glycyrrhizae 3, the seed of Chinese dodder 5, Poria cocos 10, the tuber of dwarf lilyturf 5; Every natural gift are taken for three times, each 4 grams.Control group routine is taken melbine.Two groups are consistent in diet control, kinesiatrics, and be 2 months two groups of courses for the treatment of.
1.4 observation index: measure respectively fasting blood-glucose (FPG), postprandial blood sugar (2hBG), glycosylated hemoglobin (HbA1c), FPI (FINS), blood fat (TC, TG, HDL-C, LDL-C) before and after treatment, blood sugar determination of glucose oxidase, insulin is measured with putting the method for exempting from, blood fat is measured with automatic clinical chemistry analyzer, HOMA-IR employing Haffner etc. [3,4] in Homa model, calculate the formula of IR, be HOMA-IR=FPG * FINS/22.5 (FPG unit is mmol/L, and FINS unit is mU/L).
1.5 statistical methods: adopt SPSS 14.0 statistical analysis softwares to carry out statistical procedures.Measurement data adopts t check, enumeration data chi-square criterion.
2 results: before and after two groups of treatments, the variation of FPG, 2hBG, HbAIc, FINS and HOMA-IR refers to table 1.By in table 1, we can see, treat front two groups of patient FPG, 2hBG, HbAlc, FINS, the horizontal comparing difference not statistically significant of HOMA-IR (P>0.05); After treating, two groups of FPG, 2hBG, HbAlc, FINS, HOMA-IR levels have statistical significance (P<0.05 or P<0.01) with the front comparing differences for the treatment of, before treatment group patient's These parameters and treatment, relatively have significant difference (P<0.01).Prompting treatment group and control group all can reduce diabetes blood sugar, but it is more obvious with treatment group, to improve blood sugar.
The variation of FPG, 2hBG, HbAlc, FINS and HOMA-IR before and after table 1 liang group patient treatment
Note: indices is compared with before treatment: * P<0.05, * * P<0.01; The rear two groups of FINS for the treatment of and HOMA-IR compare ^P<0.05, ^^P<0.01.
Before and after two groups of patient treatments, the variation of TC, TG, HDL-C, LDL-C is in Table 2.From table 2, we can see the front two groups of patients' for the treatment of the horizontal comparing difference not statistically significant of TC, TG, HDL-C, LDL-C (P>0.05); After treatment, TC, TG, HDL-C, the LDL-C level of two groups have significant change, wherein TC, TG, LDL-C level have statistical significance (P<0.05) with the front comparing difference for the treatment of, and relatively have significant difference (P<0.01) before treatment group HDL-C level and treatment.Illustrate that treatment group and control group all can improve diabetic's blood lipid level, and more remarkable with treatment group effect.
The variation of TC, TG, HDL-C, the horizontal content of LDL-C before and after table 2 liang group patient treatment
Note: indices is compared with before treatment: * P<0.05, * * P<0.01; After treatment, two groups of indices are compared ^P<0.05, ^^P<0.01.
The specific embodiment
Embodiment 1: a kind of health care that prevents and treats hyperglycaemia, to shrimp intestines, comprises the raw material of following weight: to shrimp 8-10 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, salt 0.2-0.4 kilogram, 0.4 kilogram of xylitol, 0.7 kilogram of Shaoxing rice wine, 0.4 kilogram of sesame oil, 0.05 kilogram of five-spice powder; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
Preparation method: 1, first rub into meat stuffing shrimp is put into meat grinder, then mix into pasty state thoroughly together with putting in container with other batching, pickle 2-4 hour, enter sausage filler; 2. sausage filler is inserted in in casing one end and records, record full, mono-of every 20CM, button is beaten at two; Sausage is air-dry 3., then put into steam copper, boiling 20-30 minute is well-done, takes out cooling.
Embodiment 2: a kind of health care that prevents and treats hyperglycaemia, to shrimp intestines, comprises the raw material of following weight: to shrimp 8-10 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, salt 0.2-0.4 kilogram, 0.4 kilogram of xylitol, 0.7 kilogram of Shaoxing rice wine, 0.4 kilogram of sesame oil, 0.05 kilogram of five-spice powder; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Preparation method is with embodiment 1.
Claims (2)
1. prevent and treat the health care of hyperglycaemia to shrimp intestines, it is characterized in that comprising the raw material of following weight: to shrimp 8-10 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, salt 0.2-0.4 kilogram, 0.4 kilogram of xylitol, 0.7 kilogram of Shaoxing rice wine, 0.4 kilogram of sesame oil, 0.05 kilogram of five-spice powder; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
2. prevent and treat the health care of hyperglycaemia to shrimp intestines, it is characterized in that comprising the raw material of following weight: to shrimp 8-10 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, salt 0.2-0.4 kilogram, 0.4 kilogram of xylitol, 0.7 kilogram of Shaoxing rice wine, 0.4 kilogram of sesame oil, 0.05 kilogram of five-spice powder; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410175285.2A CN103919175A (en) | 2014-04-29 | 2014-04-29 | Prawn sausage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410175285.2A CN103919175A (en) | 2014-04-29 | 2014-04-29 | Prawn sausage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103919175A true CN103919175A (en) | 2014-07-16 |
Family
ID=51137759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410175285.2A Pending CN103919175A (en) | 2014-04-29 | 2014-04-29 | Prawn sausage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103919175A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104397772A (en) * | 2014-12-23 | 2015-03-11 | 蒋科富 | Prawn meat sausages with function of controlling tumors |
| CN107223900A (en) * | 2017-07-31 | 2017-10-03 | 青岛河澄知识产权有限公司 | A kind of low fat high calcium seafood intestines |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102894390A (en) * | 2012-09-15 | 2013-01-30 | 牛岷 | Cosmetic flavor beef sausage |
| CN102934806A (en) * | 2012-11-29 | 2013-02-20 | 蒋科富 | Mutton sausage |
| CN102940255A (en) * | 2012-11-29 | 2013-02-27 | 蒋科富 | Beef sausage |
| CN103704761A (en) * | 2013-12-18 | 2014-04-09 | 芜湖中路实业有限责任公司 | Beef sausage and processing method thereof |
-
2014
- 2014-04-29 CN CN201410175285.2A patent/CN103919175A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102894390A (en) * | 2012-09-15 | 2013-01-30 | 牛岷 | Cosmetic flavor beef sausage |
| CN102934806A (en) * | 2012-11-29 | 2013-02-20 | 蒋科富 | Mutton sausage |
| CN102940255A (en) * | 2012-11-29 | 2013-02-27 | 蒋科富 | Beef sausage |
| CN103704761A (en) * | 2013-12-18 | 2014-04-09 | 芜湖中路实业有限责任公司 | Beef sausage and processing method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104397772A (en) * | 2014-12-23 | 2015-03-11 | 蒋科富 | Prawn meat sausages with function of controlling tumors |
| CN107223900A (en) * | 2017-07-31 | 2017-10-03 | 青岛河澄知识产权有限公司 | A kind of low fat high calcium seafood intestines |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102783669B (en) | Processing method of medicated diet ready-to-eat sea cucumber | |
| CN103919176A (en) | Lobster meat sausage | |
| CN103907957A (en) | Bamboo rat sausage | |
| CN103919153A (en) | Healthcare quail sausage | |
| CN103919175A (en) | Prawn sausage | |
| CN103947925A (en) | Buckwheat porridge | |
| CN103919022A (en) | Health-care steamed buns for preventing and treating hyperglycemia | |
| CN103919162A (en) | Mutton sausage | |
| CN103932226A (en) | Venison sausage | |
| CN103907963A (en) | Crocodile meat sausage | |
| CN103919155A (en) | Healthcare pigeon sausage | |
| CN103907970A (en) | Whitebait meat balls | |
| CN103947916A (en) | Jelly | |
| CN103907952A (en) | Health-care ostrich meat sausage | |
| CN103907956A (en) | Health horsemeat sausage | |
| CN103931772A (en) | Milk tea | |
| CN105661305A (en) | Making method of healthcare rice cake capable of resisting cold | |
| CN103931999A (en) | Beef sausage | |
| CN103919163A (en) | Ass meat sausage | |
| CN103919161A (en) | Healthcare pork sausage | |
| CN103918740A (en) | Premixed powder for preventing and treating hyperglycemia | |
| CN103919154A (en) | Health-care chicken sausage | |
| CN103907951A (en) | Health-care duck meat sausage | |
| CN103907969A (en) | Reeves shad meat ball | |
| CN103931996A (en) | Health-care goose meat sausage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140716 |